DIVA Laboratories Ltd (4153) — Capital Reinvestment Ratio
DIVA Laboratories Ltd (4153) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow (NT$5.57 Million) in capital expenditures (NT$241.00K). Check tangible equity quality of DIVA Laboratories Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
DIVA Laboratories Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks DIVA Laboratories Ltd's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see DIVA Laboratories Ltd cash conversion from operations.
Annual Capital Reinvestment Ratio for DIVA Laboratories Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for DIVA Laboratories Ltd from 2017 to 2025. See DIVA Laboratories Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | NT$20.77 Million | NT$1.00 Million | ▲ +178.2% |
| 2024 | 0.02x | NT$123.14 Million | NT$2.13 Million | ▼ -43.1% |
| 2023 | 0.03x | NT$252.91 Million | NT$7.69 Million | ▼ -80.5% |
| 2022 | 0.16x | NT$73.19 Million | NT$11.42 Million | ▼ -35.8% |
| 2019 | 0.24x | NT$52.66 Million | NT$12.79 Million | ▼ -3.8% |
| 2018 | 0.25x | NT$86.02 Million | NT$21.71 Million | ▼ -21.4% |
| 2017 | 0.32x | NT$41.45 Million | NT$13.31 Million | — |